145 related articles for article (PubMed ID: 9616190)
21. YC-1 enhances the responsiveness of tolerant vascular smooth muscle to glyceryl trinitrate.
O'Reilly DA; McLaughlin BE; Marks GS; Brien JF; Nakatsu K
Can J Physiol Pharmacol; 2001 Jan; 79(1):43-8. PubMed ID: 11201500
[TBL] [Abstract][Full Text] [Related]
22. The role of lipoic acid in prevention of nitroglycerin tolerance.
Dudek M; Bednarski M; Bilska A; Iciek M; Sokołowska-Jezewicz M; Filipek B; Włodek L
Eur J Pharmacol; 2008 Sep; 591(1-3):203-10. PubMed ID: 18616939
[TBL] [Abstract][Full Text] [Related]
23. Phosphodiesterase type 5 inhibitor sildenafil citrate does not potentiate the vasodilative properties of nebivolol in rat aorta.
Rosenkranz S; Brixius K; Halbach R; Diedrichs H; Schwinger RH
Life Sci; 2006 Feb; 78(10):1103-7. PubMed ID: 16297411
[TBL] [Abstract][Full Text] [Related]
24. Lack of evidence for the involvement of cytochrome P-450 or other hemoproteins in metabolic activation of glyceryl trinitrate in rabbit aorta.
Liu Z; Brien JF; Marks GS; McLaughlin BE; Nakatsu K
J Pharmacol Exp Ther; 1993 Mar; 264(3):1432-9. PubMed ID: 8450477
[TBL] [Abstract][Full Text] [Related]
25. Effects of nitrovasodilators on the human fetal-placental circulation in vitro.
Zhang XQ; Kwek K; Read MA; Donoghue JF; Walters WA
Placenta; 2001 Apr; 22(4):337-46. PubMed ID: 11286570
[TBL] [Abstract][Full Text] [Related]
26. Relative potency and arteriovenous selectivity of nitrovasodilators on human blood vessels: an insight into the targeting of nitric oxide delivery.
MacAllister RJ; Calver AL; Riezebos J; Collier J; Vallance P
J Pharmacol Exp Ther; 1995 Apr; 273(1):154-60. PubMed ID: 7714761
[TBL] [Abstract][Full Text] [Related]
27. Increased permeability of the blood-brain barrier following administration of glyceryl trinitrate in common carp (Cyprinus carpio L.).
Kovacić S; Petrinec Z; Matasin Z; Gjurcević E; Ivkić G; Lovreneić-Huzjan A; Segvić-Klarić M; Rumora L; Pepeljnjak S
Coll Antropol; 2008 Jan; 32 Suppl 1():99-103. PubMed ID: 18405066
[TBL] [Abstract][Full Text] [Related]
28. Vascular and anti-platelet actions of 1,2- and 1,3-glyceryl dinitrate.
Salvemini D; Pistelli A; Anggard E
Br J Pharmacol; 1993 Nov; 110(3):937-42. PubMed ID: 8298817
[TBL] [Abstract][Full Text] [Related]
29. Role of mitochondrial aldehyde dehydrogenase in nitrate tolerance.
DiFabio J; Ji Y; Vasiliou V; Thatcher GR; Bennett BM
Mol Pharmacol; 2003 Nov; 64(5):1109-16. PubMed ID: 14573760
[TBL] [Abstract][Full Text] [Related]
30. Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates.
Daiber A; Oelze M; Coldewey M; Bachschmid M; Wenzel P; Sydow K; Wendt M; Kleschyov AL; Stalleicken D; Ullrich V; Mülsch A; Münzel T
Mol Pharmacol; 2004 Dec; 66(6):1372-82. PubMed ID: 15331769
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of interaction between the sulfhydryl precursor L-methionine and glyceryl trinitrate.
Münzel T; Mülsch A; Holtz J; Just H; Harrison DG; Bassenge E
Circulation; 1992 Sep; 86(3):995-1003. PubMed ID: 1355413
[TBL] [Abstract][Full Text] [Related]
32. Endothelin receptor antagonism does not prevent the development of in vivo glyceryl trinitrate tolerance in the rat.
Ratz JD; Fraser AB; Rees-Milton KJ; Adams MA; Bennett BM
J Pharmacol Exp Ther; 2000 Nov; 295(2):578-85. PubMed ID: 11046091
[TBL] [Abstract][Full Text] [Related]
33. Role of protein kinase G in nitric oxide deficiency-induced supersensitivity to nitrovasodilator in rat pulmonary artery.
Gupta PK; Subramani J; Singh TU; Leo MD; Sikarwar AS; Prakash VR; Mishra SK
J Cardiovasc Pharmacol; 2008 May; 51(5):450-6. PubMed ID: 18418274
[TBL] [Abstract][Full Text] [Related]
34. NO donors. Part 18: Bioactive metabolites of GTN and PETN--synthesis and vasorelaxant properties.
Lange K; Koenig A; Roegler C; Seeling A; Lehmann J
Bioorg Med Chem Lett; 2009 Jun; 19(11):3141-4. PubMed ID: 19406636
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of platelet aggregation with glyceryl trinitrate and xanthine oxidoreductase.
O'Byrne S; Shirodaria C; Millar T; Stevens C; Blake D; Benjamin N
J Pharmacol Exp Ther; 2000 Jan; 292(1):326-30. PubMed ID: 10604966
[TBL] [Abstract][Full Text] [Related]
36. Discrepancies between nitroglycerin and NO-releasing drugs on mitochondrial oxygen consumption, vasoactivity, and the release of NO.
Núñez C; Víctor VM; Tur R; Alvarez-Barrientos A; Moncada S; Esplugues JV; D'Ocón P
Circ Res; 2005 Nov; 97(10):1063-9. PubMed ID: 16224067
[TBL] [Abstract][Full Text] [Related]
37. Nitrate tolerance is specific for nitric acid esters and its recovery requires an intact protein synthesis.
Hinz B; Schröder H
Biochem Biophys Res Commun; 1998 Nov; 252(1):232-5. PubMed ID: 9813175
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of phosphodiesterase 5 selectively reverses nitrate tolerance in the venous circulation.
MacPherson JD; Gillespie TD; Dunkerley HA; Maurice DH; Bennett BM
J Pharmacol Exp Ther; 2006 Apr; 317(1):188-95. PubMed ID: 16330494
[TBL] [Abstract][Full Text] [Related]
39. Formation of releasable NO stores by S-nitrosoglutathione in arteries exhibiting tolerance to glyceryl-trinitrate.
Sarr M; Lobysheva I; Diallo AS; Stoclet JC; Schini-Kerth VB; Muller B
Eur J Pharmacol; 2005 Apr; 513(1-2):119-23. PubMed ID: 15878716
[TBL] [Abstract][Full Text] [Related]
40. S-nitrosating nitric oxide donors induce long-lasting inhibition of contraction in isolated arteries.
Alencar JL; Lobysheva I; Chalupsky K; Geffard M; Nepveu F; Stoclet JC; Muller B
J Pharmacol Exp Ther; 2003 Oct; 307(1):152-9. PubMed ID: 12954813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
